Prosecution Insights
Last updated: October 27, 2026

Dawn Marie Bickham, USPTO Patent Examiner

Listed by the USPTO as BICKHAM, DAWN MARIE

Tech Center 3600 • Art Units: 1685 3676

This examiner grants 44% of resolved cases

Analysis

BICKHAM, DAWN MARIE has 41 resolved cases in technology center 3600 and art unit 1685. The allowance rate is 43.9%, and the median time to allowance is 1578 days.

Interview lift is 65.7%, indicating a strong positive association with allowance. The listed companies are NEC Laboratories America Inc., Illumina Inc., and NEC Corporation. The listed firms include GREENBERG TRAURIG, LLP (BOS), JCIPRNET, and Jones Day. The limited case volume means the large interview association should be treated as a record-specific signal rather than a general expectation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

43.9%
Allow Rate
-8.1% vs TC avg
75
Total Applications
+65.7%
Interview Lift
1578
Avg Prosecution Days
Based on 41 resolved cases, 2023–2026

Rejection Statute Breakdown

34.3%
§101 Eligibility
11.8%
§102 Novelty
24.4%
§103 Obviousness
23.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17765929 STRESS ANALYSIS APPARATUS, STRESS ANALYSIS METHOD, AND COMPUTER-READABLE RECORDING MEDIUM Final Rejection NEC Corporation
19288834 GENERATIVE PROTEIN DESIGN WITH SMOOTHED ENERGY-BASED MODELS Final Rejection Genentech, Inc.
18479416 A PEPTIDE BASED VACCINE GENERATION SYSTEM WITH DUAL PROJECTION GENERATIVE ADVERSARIAL NETWORKS Non-Final OA NEC Laboratories America, Inc.
17510882 PEPTIDE-BASED VACCINE GENERATION Final Rejection NEC Laboratories America, Inc.
16278611 GAN-CNN FOR MHC PEPTIDE BINDING PREDICTION Final Rejection REGENERON PHARMACEUTICALS, INC.
18089565 IDENTIFICATION SYSTEM OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, DEVELOPMENT METHOD OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, CANCER DETECTION METHOD AND KIT Final Rejection Industrial Technology Research Institute
18026376 PREDICTING PROTEIN STRUCTURES BY SHARING INFORMATION BETWEEN MULTIPLE SEQUENCE ALIGNMENTS AND PAIR EMBEDDINGS Non-Final OA DeepMind Technologies Limited
17595343 DEEP LEARNING BASED SYSTEM AND METHOD FOR PREDICTION OF ALTERNATIVE POLYADENYLATION SITE Final Rejection KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
17434455 METHODS FOR DETERMINING A DESIGNABLE REGION OF OLIGONUCLEOTIDES Final Rejection SEEGENE, INC.
18477346 COPY NUMBER VARIATION (CNV) BREAKPOINT DETECTION Non-Final OA Illumina, Inc.
18301595 TARGETED CALLING OF OVERLAPPING COPY NUMBER VARIANTS Non-Final OA Illumina, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Dawn Marie Bickham's allowance rate?

43.9% of resolved applications examined by Dawn Marie Bickham were allowed (41 resolved cases), compared with 40.5% across Art Unit 1685 over the last five years.

Does an interview help with examiner Dawn Marie Bickham?

This examiner's interview lift is +65.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Dawn Marie Bickham take to allow a patent?

Applications allowed by Dawn Marie Bickham took 1,578 days on average from filing to allowance.

Which art unit does examiner Dawn Marie Bickham work in?

Dawn Marie Bickham examines applications in Art Unit 1685 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month